Physician profile
Robin Danielson
NPI 1578147575
$1,229.09
in general payments reported to CMS, 2019-2025
13 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.29 · 2022: $152 · 2023: $440 · 2024: $256 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $358.13 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Collegium Pharmaceutical, INC. | $305.00 | 2023-2025 | Belbuca, Xtampza |
| Nevro Corp. | $179.01 | 2023-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $59.29 | 2021 | |
| Abbvie INC. | $48.93 | 2024 | |
| Relievant Medsystems, INC. | $48.48 | 2023 | Intracept |
| Horizon Therapeutics Plc | $42.86 | 2022 | |
| Globus Medical, INC. | $41.32 | 2025 | Senza |
| Boston Scientific Corporation | $38.20 | 2023-2025 | Watchman Flx, Wavewriter Alpha Prime 16 |
| Valinor Pharma, LLC | $33.78 | 2025 | Movantik |
| Spr Therapeutics, INC | $28.48 | 2023 | Sprint Pns System |
| Fidia Pharma USA INC. | $27.44 | 2023 | Triluron, Hymovis |
| Scilex Pharmaceuticals INC. | $18.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Danielson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.